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Abstract 
The impact of agitation rate and sparged aeration on BM-hMSC expansion in conventional stirred tank 
bioreactors was assessed. It was found that a decrease in impeller speed to below NJS caused sampling 
difficulties, clumping and an increase to ~2 NJS decreased the growth rate though an intermediate value of ~1.3 
NJS did not. Additionally, over this range of agitation intensities, cell quality remained unchanged post-harvest 
suggesting that poor growth performance at the highest speed was due to a failure of the cells to attach 
efficiently to microcarriers rather than damage to the cells due to fluid dynamic stress. Further it was shown that 
direct aeration of the culture medium both with and without Pluronic F68 via a sparger at NJS was detrimental to 
BM-hMSC growth. Again, this reduction in growth seems to be associated with poor attachment rather than cell 
damage, which due to the mechanism of PluronicTM F68 reducing the cell hydrophobicity and thus the affinity 
of the BM-hMSCs to attach to the microcarrier, leads to a poorer performance in the presence of the surfactant. 
Certain post-harvest quality characteristics are also detrimentally impacted compared to headspace aeration. 
This problem is discussed in terms of the need to facilitate future large-scale process development where 
headspace aeration at NJS may not be sufficient to meet culture needs at higher cell densities. 
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1. Introduction 
Bone marrow-derived human mesenchymal stem cells (BM-hMSCs) have generated much interest in the field 
of regenerative medicine and cell-base therapies, with the potential to treat and in some cases, cure human 
disease. This interest has been largely driven by their ability to proliferate under appropriate culture conditions 
and their capacity to secrete a range of trophic factors which regulate host immune response and initiate tissue 
repair [1]. Consequently, there have been approvals for BM-hMSC-based products and multiple trials involving 
the use of the cells are advancing through clinical development targeting indications such as cardiac repair, 
neurological disease and immune disorders [2]. Microcarriers have been used to culture adherent cells such as 
BM-hMSCs in suspension [3] allowing for process scale-up, where online monitoring and control systems can 
be used to deliver a consistent and cost-effective BM-hMSC therapy. Further to this, stirred-suspension 
bioreactors are currently employed in biopharmaceutical production and therefore their design and operation are 
well-understood [4], with the potential to meet the expected manufacturing demands of large-scale BM-hMSC 
therapies [5].  
 
If the bioreactor is to work effectively, it is essential that the microcarriers are at least fully suspended in such a 
way that though they may regularly touch and move on the bottom, they do not remain stationary for any 
significant period of time, typically 5 s; that condition requires a certain minimum agitator speed to achieve it 
(usually given the symbol, NJS (rev/s)) [6]. Under these conditions, the cells on the microcarrier are always 
surrounded by culture medium and are therefore able to take up nutrients (including O2) from it and secrete 
growth-inhibiting metabolites into it. There is much emphasis in the literature on the sensitivity of cells grown 
on microcarriers to high fluid dynamic stresses generated by agitation such that the culture performance is poor 
whether dealing with animal cells for vaccine production or stem cells. There are a number of mechanisms that 
can give rise to mechanical stress on microcarriers and the cells on them; fluid motion relative to the 
microcarrier, impacts between microcarriers and the impeller or between microcarriers, and from bursting 
bubbles associated with the cells’ oxygen demand. When growing cells, there are two ways in which culture 
may be compromised; one is growth and proliferation and the other, of critical importance for regenerative 
medicine and cell-based therapy applications, is cell or product quality. In the case of BM-hMSC, the cell forms 
the basis of the product. These issues in turn may arise for two reasons: the stress will detach the cells from the 
microcarriers and subsequently performance will be compromised or the stress will damage the cell while still 
on the microcarrier. 
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Meeting the oxygen demand of cells is often considered the process requirement needing the highest agitation 
intensity. At the cell density currently achievable and operating scale used at present when growing stem cells 
on microcarriers, in general, the most demanding agitation has been that required for microcarrier suspension 
and at this condition, the oxygen demand can be met by surface aeration. The same situation existed in the early 
days of free suspension mammalian cell culture, even though cell oxygen demand is an order of magnitude 
higher than BM-hMSCs [3]. But as cell densities increased to greater than 5 x 106 cells ml-1 and bioreactor scale 
increased, up to 25 m3, aeration directly into the culture medium via the incorporation of a sparger had to be 
used [6]. This situation is likely to arise with stem cells in the future and this change may also create new 
challenges; for example, the addition of antifoam [7] into the medium, which has been previously shown to 
significantly reduce the mass transfer rate of the system [8]. It is also widely accepted that cell damage due to 
direct aeration in free suspension culture is primarily a result of cells attaching to bubbles and experiencing the 
huge energy release as they burst at the medium-air interface. Polymers such as PluronicTM F68 are widely used 
to decrease this cell damage and improve bioreactor performance [9, 10]. This improvement in performance by 
the addition of PluronicTM F68 is a result of its ability to reduce the hydrophobicity of the cell surface, 
preventing cell-bubble attachment and subsequent damage [11].  
 
The aim of this study therefore, is to assess the impact of impeller agitation rate on BM-hMSC expansion in 
stirred bioreactors and the influence of direct aeration into the culture medium on the growth and 
characterization of BM-hMSC, to facilitate future large-scale development where headspace aeration at NJS may 
not be sufficient.  
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2. Materials & Methods 
2.1 Monolayer Culture 
BM-hMSCs were isolated from bone-marrow aspirate purchased from Lonza (Walkersville, USA) obtained 
from a healthy donor with informed consent (lot: 071313B).  The local Ethical Committee approved the use of 
the sample for research.  Cells from passage 1 were cryopreserved at a density of 1-2 x 106 cells.ml-1 in a freeze 
medium containing 90% (v/v) FBS (Hyclone, Belgium) and 10% (v/v) dimethylsulphoxide (Sigma-Aldrich, 
UK). Cells were grown in T-flasks seeded at 5,000 cells.cm-2 at 37°C in humidified air containing 5% CO2. For 
serum-free culture, the growth surface of T-flasks was coated with 0.4 µg.cm-2 PRIME-XV human fibronectin 
(FN) (Irvine Scientific, USA) and cultured in PRIME-XV MSC Expansion SFM (Irvine Scientific, USA) as per 
the manufacturer’s instructions. On passage, the hMSCs were washed with phosphate buffered saline without 
Ca+ or Mg+ (PBS) and incubated for 4 min with TrypLE Express (Invitrogen, UK). Dissociation reagents were 
inactivated by the addition of appropriate growth medium and the cell suspension was centrifuged at 220g for 5 
min. The supernatant was discarded and the remaining pellet was re-suspended in an appropriate volume of 
culture medium. BM-hMSCs underwent one adaptation passage in serum-free medium.    
 
 
2.2 DASGIP DASbox bioreactor microcarrier culture 
The glass surfaces of 250 ml DASGIP DASbox bioreactors (diam. T = 60 mm) (Eppendorf, Germany) were 
siliconized with Sigmacoat (Sigma-Aldrich, UK) according to manufacturer’s instructions to prevent cell 
attachment to the surface of the bioreactor and impeller.  The bioreactors were equipped with a 3-blade 30°-
pitch, down pumping impeller (diameter, D = 30.25 mm), a temperature probe, a Hamilton dissolved oxygen 
(dO2) probe, a Hamilton pH probe, an off-gas analyser and two sterile sample ports. Solid, non-porous Plastic P-
102L microcarriers of 160-200 microns (Solohill, USA) were prepared to give 5000 cm2/l per bioreactor 
following manufacturer’s instructions. Microcarriers were coated with 0.1 µg.cm-2 PRIME-XV FN prior to 
hMSC inoculation at 6,000 cells. cm-2 and cultured in 100 ml of PRIME-XV MSC Expansion SFM with 
bioreactor control set-points of 37 °C and pH 7.4.  A 50 % medium exchange was performed every two days as 
per manufacturer’s instructions. Following inoculation, the culture was static for one hour (based on related 
work on optimizing attachment [12]) after which the culture was agitated at NJS (found to be 115 rpm) or at 
whatever agitator speed was selected for that experiment both slightly below NJS and well above it, with daily 
medium and cell-microcarrier samples of 1 ml taken for analysis. The DASbox system was set up, calibrated 
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and controlled using the DASGIP DASbox control unit (Eppendorf, Germany) and was operated with headspace 
aeration to achieve sufficient gas supply to give the desired oxygen concentration. 
 
As pointed out above, the aim of this study was to assess the impact of impeller agitation intensity and bubbling 
aeration on BM-hMSC expansion in stirred bioreactors as part of an ongoing program to facilitate future large-
scale development.  The work on the impact of agitation was undertaken first and at that time, our earlier work 
conducted in an oxygen-controlled incubator for both monolayer [13] and spinner flask culture [14] indicated 
that with the same donor cells as cultured here, the performance with respect to growth kinetics was better at 
100% dO2.than at lower values when cultured over 3 passages. Thus, during the studies of agitation intensity, 
the dO2 was controlled in the DASGIP DASbox bioreactor using the DASGIP DASbox control unit (Eppendorf, 
Germany) and was operated with headspace aeration to give 100% dO2. However, subsequently during the 
present study in the DASGIP DASbox bioreactor [15], it was found that 25% dO2 gave a better performance. 
So, whilst overall some literature studies have shown 100% dO2 gives enhanced growth kinetics and others, 
lower dO2 values [14], it was decided here to study the impact of air sparging at 25% dO2. Thus, when 
investigating the impact of air sparging, the agitator speed was set at NJS and the dO2 was controlled to 25% 
when sparging at 0.1 VVM and also with headspace aeration.  
 
Though both the topics relate to the cells’ sensitivity to fluid dynamic stresses, they can also be viewed as 
somewhat separate issues as the potential mechanisms of damage are different.   
 
2.3 DASGIP DASbox bioreactor harvest 
BM-hMSCs were harvested using a method previously developed by us [16, 17]. Briefly, the DASbox control 
was switched off and the microcarriers allowed to settle. The spent culture medium was removed and the 
microcarriers were washed twice in 50 ml of Ca2+ and Mg2+ free PBS. The PBS was removed before adding 80 
ml of TrypLE Express dissociation reagent for 10 minutes at an impeller speed of 375 rpm (ending with 5 
seconds at 400 rpm). The dissociation reagent was then quenched with 70 ml of culture medium and a 2 ml 
sample placed in a single well of a 6 well plate for analysis under a light microscope to assess cell detachment. 
The remainder of the solution was filtered through a 60 μm Steriflip Filter Unit (Merck Millipore, Germany) to 
separate the microcarriers from the BM-hMSCs. The cell suspension was centrifuged, the supernatant aspirated 
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and the cell pellet re-suspended in culture medium. A cell count was then performed using a NucleoCounter NC-
3000 to assess the overall hMSC growth and the culture harvest efficiency.  
 
 
2.4 Analytical Techniques 
Analysis of glucose and lactate concentrations in the spent medium was performed using a Cedex Bio-HT 
(Roche, Germany). Cell counting, mean cell diameter and viability (via acridine orange uptake and DAPI 
exclusion) was performed using a NucleoCounter NC-3000 automated mammalian cell counter (Chemometec, 
Denmark). The following parameters were obtained: 
1. Specific Growth Rate 
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔ℎ 𝑔𝑔𝑟𝑟𝑔𝑔𝑆𝑆, µ =  ln�𝐶𝐶𝑥𝑥(𝑡𝑡) 𝐶𝐶𝑥𝑥(0)� �
∆𝑡𝑡
  
where µ is the net specific growth rate (h-1), Cx(t) and Cx(0) are the cell numbers at the end and start of the 
exponential growth phase, respectively and t is time (h).  
2. Population Doublings 
𝑃𝑃𝑔𝑔𝑆𝑆𝑃𝑃𝑃𝑃𝑟𝑟𝑔𝑔𝑆𝑆𝑔𝑔𝑃𝑃 𝐷𝐷𝑔𝑔𝑃𝑃𝐷𝐷𝑃𝑃𝑆𝑆𝑃𝑃𝑔𝑔𝐷𝐷,𝑃𝑃𝑑𝑑 = 1log  (2) ∙ log �𝐶𝐶𝑥𝑥(𝑡𝑡)𝐶𝐶𝑥𝑥(0)�  
where Pd is the number of population doublings, Cx(t) and Cx(0) are the cell numbers at the end and start of the 
exponential growth phase, respectively. 
3. Specific Metabolite Consumption/Production Rate 
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑚𝑚𝑆𝑆𝑔𝑔𝑟𝑟𝐷𝐷𝑔𝑔𝑃𝑃𝑆𝑆𝑔𝑔𝑆𝑆 𝑆𝑆𝑃𝑃𝑃𝑃𝑓𝑓, 𝑞𝑞𝑚𝑚𝑚𝑚𝑡𝑡 = � 𝜇𝜇𝐶𝐶𝑥𝑥(0)� ∙ �𝐶𝐶𝑚𝑚𝑚𝑚𝑚𝑚(𝑡𝑡)−𝐶𝐶𝑚𝑚𝑚𝑚𝑚𝑚(0)𝑚𝑚𝜇𝜇𝑚𝑚−1 �  
where qmet is the net specific metabolite consumption or production rate, µ is the specific growth rate (h-1), Cx(0) 
is the cell number at the end of the exponential growth phase, Cmet(t) and Cmet(0) are the metabolite 
concentrations at the end and start of the exponential growth phase, respectively and t is time (h).  
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2.5 Colony-forming unit fibroblast (CFU-f) Efficiency 
To assess the CFU-f efficiency, BM-hMSCs were seeded in a T-flask at 10 cells.cm-2 and cultured with a 
medium exchange every 3-5 days. Following 14 days culture, cells were washed with PBS and fixed in 4% 
formaldehyde (v/v) (Sigma, UK) for 30 minutes. Colonies were stained with 1% crystal violet (Sigma, UK) in 
100% methanol (w/v) for 30 minutes. Stained colonies that were made up of more than 25 cells were recorded 
as CFUs. 
 
2.6 hMSC Characterisation 
Immunophenotype analysis was performed by multi-parameter flow cytometry before and after the hMSC 
expansion process using a previously developed protocol [18]]. Short Tandem Repeat analysis was completed 
by LGC Standards (UK) under their cell line authentication program. Morphology images were obtained using a 
light microscope (Nikon Eclipse TS-100, UK). 
 
The hMSC differentiation was induced using PRIME-XV Differentiation SFM (Irvine Scientific, USA) as per 
manufacturer’s instructions. After 21 days, the differentiation medium was removed, cells rinsed with PBS then 
fixed with 4% (v/v) PFA at room temperature. Adipocytes were stained with 1% (w/v) Oil Red O (Sigma-
Aldrich, UK) in isopropanol at room temperature and rinsed with distilled water. Osteoblasts were incubated 
with 2.5% (v/v) silver nitrate (Sigma-Aldrich, UK) under ultraviolet light (30 minutes exposure), rinsed with 
distilled water and stained with fast violet solution (Sigma-Aldrich, UK) containing 4% (v/v) napthol AS-MX 
phosphate alkaline (Sigma-Aldrich, UK) for 45 minutes at room temperature in the dark. Chondrocytes were 
stained with 1% (w/v) Alcian blue (Sigma-Aldrich, UK) in 0.1 M hydrochloric acid (Sigma-Aldrich, UK). After 
30 minutes incubation, cells were rinsed three times with 0.1 M HCl. After staining, differentiated cells were 
visualized under a light microscope (Nikon Eclipse TS-100, UK). 
 
2.7 Statistical Analysis  
Results were deemed to be significant if p < 0.05 using a two-tailed Students t-test. 
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3. Results & Discussion 
3.1 Effect of agitation rate on BM-hMSC culture on microcarriers  
3.1.1 Expansion 
In order to support the successful expansion of BM-hMSCs on microcarriers in suspension bioreactors, it will be 
critically important to employ an agitation strategy that suspends the microcarriers without causing damage to 
the cells throughout scale-up and when higher cell densities are achieved. In order to quantify this requirement, 
the impact of different impeller speeds on the growth of BM-hMSCs on microcarriers has been assessed, whilst 
employing headspace aeration. In conjunction with this assessment, the critical turbulence parameters of the 
bioreactor system have been calculated to provide a strong theoretical basis for this comparison, which can be 
seen in Table 1.  
 
Figure 1A shows the effect of the various impeller speeds on BM-hMSC growth from daily samples over six 
days, with the highest impeller speed of 225 rpm leading to the lowest BM-hMSC growth. This is confirmed by 
the post-harvest cell counts in Figure 1B, which shows that there is significantly lower (p < 0.05) BM-hMSC 
growth at the highest impeller speed. The minimum impeller speed to suspend the microcarriers (NJS) was 
visually determined to be 115 rpm. Maintaining the microcarriers and cells in suspension is critical to ensure 
that effective mass transfer can take place [19] and to prevent attachment to the base of the bioreactor as well as 
severe cell-microcarrier clumping [14]. In addition, sampling during the run at 80 rpm was somewhat 
problematic as the microcarriers and cells were not entirely suspended and this explains why the daily cell 
concentration at 80 rpm (Figure 1A) was low compared with the post-harvest total cell number (Figure 1B).  
Therefore, though the post-harvest total cell number was the highest at this speed, the impeller speed in this 
microcarrier-based bioreactor system should still be at least 115 rpm.  
Table 1 shows the characterization of the bioreactor system at different impeller speeds with a calculation of the 
Kolmogorov microscale of turbulence for each impeller speed [17]. Considering that the size of the 
microcarriers used in this study are in the range of 125-212 µm (mean size ~ 170 µm), Table 1 shows that the 
Kolmogorov microscale at each of the investigated impeller speeds is much less than the size of the 
microcarriers but much bigger than a BM-hMSC (~ 15 to 20 µm).  Kolmogorov theory suggests that the eddies 
most likely to cause damage are those of the size of the suspended entity i.e. turbulent eddies which are the same 
size as the cell in free-suspension culture [20]. Croughan et al  [20] investigated the impact of this microscale of 
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turbulence on animal cells grown on microcarriers, with cell damage becoming significant when the microscale 
was less than or equal to about two-thirds the size of the microcarriers. A similar result was found for the 
conditions used here in spinner flasks [17]. However, as found in studies in other agitated bioreactors of 15 ml 
and 5 l [17], based on the mean microcarrier size, that BM-hMSC growth kinetics were not affected at NJS (115 
rpm) even though the  turbulent eddy size was < ~ 40% of the size of the microcarrier. Indeed, at 150 rpm 
(specific power input 0.06 W/kg) where the microscale was 1/3 of the size of the microcarrier, similar to that at 
NJS in the 15 ml ambr [17], the growth rate was similar (p > 0.05) to that measured at NJS, which is beneficial as 
the increased mean specific energy dissipation rate would enable higher oxygen demands to be met. At 225 rpm 
(mean specific energy dissipation rate 0.2 W/kg), the Kolmogorov scale is <  25% of that of the microcarriers 
and a severe reduction in performance was detected.  
 
3.1.2 Metabolite flux  
The relative flux of metabolites is an important parameter to measure and understand during the expansion 
process as it has the potential to form part of a process control system, based upon BM-hMSC characteristics. 
Figure 2A and B shows the lactate dehydrogenase (LDH) and total protein concentration at the various impeller 
speeds throughout the culture process, which do not increase as the impeller speed is changed. If cell damage 
was occurring during the culture process, the levels of LDH and total protein would increase [21]. The 
differences in BM-hMSC growth kinetics due to changes in impeller speed are therefore not attributed to 
cellular damage by membrane disruption in this instance. It has been demonstrated previously however, that 
increasing the shear stress in flow chambers during BM-hMSC culture leads to the inhibition of proliferation, in 
association with maintaining cells in the G0/G1 phase of the cell cycle [22]. Additionally, the reduction in 
growth kinetics at higher impeller speeds could be caused by an inhibition of BM-hMSC attachment and re-
attachment to the microcarriers during the growth phase. Whatever the mechanism for the reduced growth rate 
of BM-hMSCs on microcarriers at increased impeller speeds, it is not caused by direct cell damage as is 
commonly assumed.  
The net flux of each metabolite can be seen in Figure 3A and B, which shows an increase in ammonia 
production and yield of lactate from glucose at higher impeller speeds. The effect of impeller speed on the live 
metabolite concentrations during BM-hMSC expansion in controlled microcarrier culture can be seen in 
Supplementary Figure 1. The increased ammonia production at an impeller speed suggests altered amino acid 
utilisation, which may be related to the increased need for precursors (e.g., glutamine and asparagine) 
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supporting purine, and pyrimidine biosynthesis [23]. The yield of lactate from glucose for impeller speeds of 80, 
115 and 150 rpm was around 2 mol.mol-1 which indicates that the cells mainly metabolise glucose via the 
inefficient glycolytic pathway instead of oxidative phosphorylation [24]. The impeller speed of 225 rpm had a 
yield of lactate from glucose of 2.70 ± 0.73 mol.mol-1 which is above the theoretical maximum yield of 2 
mol.mol-1 [25]. The high figure at 225 rpm suggests that an additional carbon source, most likely glutamine, is 
being metabolised to produce lactate and ammonia, resulting in higher lactate yields and an increase in the per 
cell ammonia flux [3] seen in Figure 3A.  These findings are in line with previously published articles for both 
microcarrier and monolayer culture [26, 27].     
 
3.1.3 Quality characteristics 
In addition to the growth kinetics and metabolite flux, it is important to assess the post-harvest BM-hMSC 
characteristics to ensure that the process and harvest conditions have not had a detrimental impact on the quality 
of the cell [16]. The BM-hMSCs were harvested from the microcarrier surface and separated prior to 
characterization according to a previously published protocol for the DASGIP DASbox bioreactor platform [17], 
maintaining a post-harvest viability of >95% in all conditions. The specific outgrowth rate can be seen in Figure 
4A which shows that the BM-hMSC post-harvest outgrowth rate was similar across all the impeller speeds 
investigated in the bioreactor. This similarity suggests that the impeller speed of 225 rpm has not triggered a 
senescent state in the BM-hMSCs or caused detriment to their outgrowth potential. This result is further 
evidence to support the hypothesis that the reduction of BM-hMSC growth kinetics on microcarriers at high 
impeller rates is due to inefficient cell-microcarrier attachment, rather than cell damage due to increasing fluid 
dynamic stresses. This finding also gives further support to the use of high agitation intensity as an aid to cell 
detachment during harvest [16, 17].  
 
It can also be seen from Figure 4A that the post-harvest outgrowth kinetics of BM-hMSCs from the controlled 
DASbox bioreactor system at all impeller speeds were higher than either before expansion and post-harvest 
from the relatively-uncontrolled spinner flask process. This higher rate is an indication of the positive impact 
that control of the environment in the bioreactor is having on the BM-hMSC characteristics, which will be 
important for future bioprocess scale-up and development.       
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Associated with the increase in post-harvest outgrowth, the BM-hMSCs cultured in the DASbox bioreactor 
platform had a reduced mean cell diameter (Figure 4B) for all impeller speeds compared to pre-expansion and 
post-harvest from relatively-uncontrolled spinner flasks. As well as being associated with a decrease in BM-
hMSC growth rate [28], an increase in cell size has been linked to aging of BM-hMSCs and loss in 
differentiation potential [29, 30] and therefore a reduction in BM-hMSC size through controlled microcarrier 
expansion will be beneficial to the manufacturing process. Colony forming potential has been highlighted as an 
important assay for the quality of BM-hMSC preparations [31] and is known to deteriorate during culture [32, 
33]. Figure 4C shows the maintenance of colony forming potential from pre-expansion to post-harvest at all 
impeller speeds, which further demonstrates that the BM-hMSCs have not been damaged during the expansion 
and harvest process. Furthermore, BM-hMSCs have retained their immunophenotype and differentiation 
potential according to the ISCT minimum criteria (supplementary Figure 2).   
 
3.2 Effect of sparged aeration on BM-hMSC culture on microcarriers 
3.2.1 Expansion 
Like agitation intensity, aeration strategies will play a key role in the successful development of microcarrier 
based bioreactor processes for BM-hMSC manufacture, particularly as the scale of operation and product cell 
density increases. Due to the fact that the specific oxygen demand and the cell densities achieved so far in BM-
hMSC microcarrier culture are low, the oxygen demand of the cells in current benchtop bioreactors can be met 
by passing gas mixtures through the headspace. However, at the commercial scale, as the surface area to volume 
ratio is inversely proportional to scale, sparging will probably be required [4]. This issue is particularly 
important because in free suspension culture, bursting bubbles can be much more damaging than agitation and 
the addition of Pluronic F68 is required to prevent it [4].  
 
To address this issue, BM-hMSCs have been cultured with sparged sub-surface aeration at 0.1 VVM, with and 
without PluronicTM F68 in the medium, and compared to headspace aeration, (all with dO2 controlled at 25%).  
Figure 5A shows the growth rate over six days of bioreactor expansion, demonstrating that headspace aeration 
(1.70 ± 0.45 x 105 cell.ml-1 or 3.4 ± 0.9 x 104 cell.cm-2) supports significantly higher (p < 0.05) growth kinetics 
compared to sparged culture with (0.52 ± 0.15 x 105 cell.ml-1 or 1.04 ± 0.3 x 104 cell.cm-2) and without (0.84 ± 
0.18 x 105 cell.ml-1 or 1.68 ± 0.36 x 104 cell.cm-2) PluronicTM F68. This study is the first indication that aeration 
directly into the culture medium via a sparger has a detrimental impact on the expansion of BM-hMSCs on 
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microcarriers. The cells ml-1 after 6 days when sparging in the presence of PluronicTM F68 is slightly higher than 
without it; and both are markedly lower than with headspace aeration. Interestingly, the addition of this 
surfactant  has been shown to be effective in an alternative cell-microcarrier culture [34].  
This results suggests that the detrimental impact of direct aeration on the microcarrier culture of BM-hMSCs is 
not simply due to cell-bubble attachment, with cell damage caused by subsequent bubble bursting at the gas-
liquid interface as is the case with free suspension cell culture [11]. The key difference with the microcarrier 
culture of BM-hMSCs compared to free suspension cell culture is that the cells must adhere to the microcarrier 
surface prior to growth. The addition of PluronicTM F68 into the culture medium in this system is in fact having 
a detrimental impact on the growth of BM-hMSCs, which perhaps is not surprising given that the mechanism of 
PluronicTM F68 is to reduce the cell hydrophobicity, thus reducing the affinity of the BM-hMSCs to attach to the 
microcarrier or bubble surface. Further evidence of this hypothesis can be seen in Figure 5B, which shows the 
attachment rate of the BM-hMSCs to the microcarriers during the six days of culture. This figure shows that the 
attachment rate of the BM-hMSCs is reduced in sparged culture compared to headspace aeration, suggesting 
that introducing bubbles into the bioreactor system is disrupting the BM-hMSC attachment process. 
Additionally, the inclusion of PluronicTM F68 in the culture medium is further reducing the attachment rate of 
the BM-hMSCs to the microcarriers in suspension, in accordance with the mechanism described above. This 
reduced attachment rate of BM-hMSCs is likely to be contributing to the reduced growth rate seen under 
sparged conditions for BM-hMSCs cultured on microcarriers.  
 
3.2.2  Metabolite flux  
In addition to growth rate, the metabolite flux has been monitored throughout culture to assess the impact that 
direct aeration is having on the consumption and production of metabolites throughout microcarrier culture. 
Figure 6A, B and C show the per cell flux of glucose, lactate and ammonia respectively and Figure 6D, the yield 
of lactate from glucose throughout the six days of expansion for sparged and headspace aeration culture. These 
figures show that despite the reduced growth rate, the net flux of glucose, lactate and ammonia is similar for all 
conditions and again did not reach previously determined inhibitory levels at any point [35]. The per cell flux of 
each metabolite shows a similar level of net glucose consumption per cell in headspace and sparged aeration 
during culture. In contrast, the production of ammonia to above 3 pmol.cell-1.day-1 and lactate to above 20 
pmol.cell-1.day-1 in sparged culture was significantly higher (p < 0.05) than from headspace aeration. The 
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increase in the per cell production of lactate and ammonia has previously been associated with a reduction in 
growth kinetics of BM-hMSCs throughout an expansion process [33]. As with the previous experiments, the 
LDH and total protein concentrations have been measured to assess whether any BM-hMSC stress or damage 
has been caused by sparged aeration. Supplementary Figures 3A and B show these concentrations throughout 
culture, which have not increased over the six-day period in any condition. This finding is further evidence to 
suggest that introducing sparged aeration into the culture is not causing cell damage by bubble bursting, as the 
level of LDH and total protein would be increasing throughout culture if cell damage was occurring, which is 
the likely reason why the addition of PluronicTM F68 into sparged culture is not improving the BM-hMSC 
growth rate on microcarriers. Considering that cell damage is not occurring during sparged aeration, this 
provides further evidence that the reduction in growth rate during direct aeration is caused by the reduction in 
attachment rate at the start of culture or increased detachment during culture.  
3.2.3 Quality characterization  
The post-harvest BM-hMSC number in Figure 7A further supports the previous findings, that a significantly 
higher (p < 0.05) number of BM-hMSCs were produced under headspace aeration, compared to sparged aeration 
in the controlled bioreactor process. Figure 7D shows that the post-harvest BM-hMSC mean diameter is 
increased for sparged culture, with a significant increase (p < 0.05) seen for sparged aeration with the addition of 
PluronicTM F68. This increase in post-harvest cell size is associated with a reduction in BM-hMSC attachment 
and subsequent growth rate with the addition of PluronicTM F68, as was seen previously for an impeller speed of 
225 rpm. In addition to the increased post-harvest BM-hMSC diameter, the addition of PluronicTM F68 into the 
sparged culture lead to a reduction in BM-hMSC outgrowth kinetics (Figure 7C) as well as a significant 
reduction (p < 0.05) in the CFU potential of the BM-hMSCs (Figure 7B). This reduction raises concerns about 
the use of PluronicTM F68 in the culture of BM-hMSCs on microcarriers and its inclusion in cell-based therapy 
manufacturing processes should be carefully considered to ensure that it is not having a detrimental impact on 
the growth or quality of the cell product.   
 
4.  Conclusions 
A range of impeller agitation speed have been used during the microcarrier expansion of BM-hMSCs from 
values below the minimum required to just suspend the microcarriers, NJS, (the commonly recommended value 
for culture) to values ~ 2 NJS. The lower value was to assess the impact of poor suspension; and higher values, 
the impact when the O2 demand cannot be met at NJS due to increasing cell density or scale.  Though the 
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decrease to below NJS gave the highest post-harvest total cell number, there were inconsistencies between pre 
and post because of sampling difficulties. In addition, poor suspension leads to increased clumping. At the other 
extreme at a speed of ~ 2 NJS, the growth rate significantly decreased. However, at ~ 1.3 NJS, the results were 
very similar to those at NJS, indicating the potential for higher mass transfer rates from agitation. In addition, 
over this range of agitation intensity, there was not any detrimental impact on the BM-hMSC post-harvest re-
growth characteristics.  
 
Direct aeration of the culture medium both with and without Pluronic F68 in it via a sparger at NJS, again 
relating to potential increasing mass transfer needs, has also been shown to be detrimental to BM-hMSC growth 
and certain post-harvest quality characteristics compared to headspace aeration. Direct aeration of the medium 
during bioreactor culture is not only likely to be required at the large-scale to supply oxygen to the cells but as 
importantly, to remove carbon dioxide. It is currently the preferred method of aeration and CO2 stripping in 
large scale bioreactors for free suspension cell culture. Therefore, it will potentially be important during process 
scale-up; and to ensure that bioreactor parameters such as the specific energy dissipation rate and sparged 
aeration rates are not increased above levels which might affect the growth and quality characteristics of the 
BM-hMSC product. Thus, alternative methods of supplying sufficient levels of oxygen to microcarrier 
bioreactor systems culturing BM-hMSCs may have to be developed as well as establishing the level of pCO2 
that they can tolerate as these systems are scaled up to manufacture commercially-viable cell numbers.  
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Figure Legends 
Figure 1 – Effect of bioreactor impeller speed on BM-hMSC growth over six days of culture in the DASbox 
controlled bioreactor, showing (A) the increased cell concentration in the bioreactor over six days at all impeller 
speeds, (B) the significant fall (p < 0.05) in total post-harvest cell number at the highest impeller speed. Control 
set-points are 100% dissolved oxygen and pH 7.4 with headspace aeration. Data shows mean ± SD, n = 3. 
 
 
Figure 2 – Effect of impeller speed on A) the production of lactate dehydrogenase (LDH) and B) total protein 
concentration during microcarrier culture of BM-hMSCs in a controlled bioreactor. Showing no significant 
increase in LDH concentration or total protein at various impeller speeds, demonstrating low levels of cell 
damage during culture. Data shows mean ± SD, n = 3.  
 
Figure 3 – Effect of bioreactor impeller speed on BM-hMSC metabolite flux over six days of culture in the 
DASbox controlled bioreactor, showing (A) per cell flux of ammonia and (B) yield of lactate from glucose. 
Control set-points are 100% dissolved oxygen and pH 7.4 with headspace aeration. Data shows mean ± SD, n = 
3. 
 
Figure 4 – Post-harvest characteristics of BM-hMSCs from controlled microcarrier culture compared to spinner 
flasks [14]. Showing (A) increased outgrowth kinetics, (B) reduced mean cell diameter and (C) maintained CFU 
efficiency all impeller speeds. Data shows mean ± SD, n = 3.        
 
Figure 5 – Effect of sparging (VVM = 0.1) with and without PluronicTM F68 on BM-hMSC growth over six 
days of controlled microcarrier culture compared to headspace aeration. Showing (A) significantly increased 
growth rate with headspace aeration (p < 0.05), and (B) reduced BM-hMSC attachment in sparged culture, 
particularly with the addition of PluronicTM F68. Control set-points are 115rpm impeller speed, 25% DO 
concentration and pH 7.4. Data shows mean ± SD, n = 3.  
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Figure 6 – Effect of sparging (VVM = 0.1) with and without PluronicTM F68 compared to headspace aeration on 
BM-hMSC metabolite flux over six days of controlled microcarrier culture . Showing (A) similar glucose 
consumption rate, (B) increased lactate production, (C) significantly increased ammonia production rate (p < 
0.05) and (D) similar yield of lactate from glucose in sparged culture. Control set-points are 115rpm impeller 
speed, 25% dO2 concentration and pH 7.4. Data shows mean ± SD, n = 3.  
 
Figure 7 – Effect of sparging (VVM = 0.1) with and without PluronicTM F68 on BM-hMSC attachment and 
post-harvest characteristics after six days of controlled microcarrier culture compared to headspace aeration. 
Showing (A) significantly reduced harvest cell number (p < 0.05), (B) decreased CFU efficiency, (C) similar 
specific outgrowth rate and (D) significantly increased mean cell diameter in sparged culture (p < 0.05). Control 
set-points are 115rpm impeller speed, 25% dO2 concentration and pH 7.4. Data shows mean ± SD, n = 3.  
 
Table 1 –Fluid dynamic characterisation of the DASGIP DASbox bioreactor platform at the various impeller 
speeds used in this study (impeller diameter of 0.03 m and a bioreactor diameter of 0.063 m). (Based on the 
procedure set out in Nienow et al. 2016 [17]). 
 
Supplementary Figures 
 
Supplementary Figure 1 – Effect of impeller speed on the live metabolite concentrations during BM-hMSC 
expansion in controlled microcarrier culture at 100% dO2 with headspace aeration. Showing (A) glucose, (B) 
lactate and (C) ammonia concentrations at various impeller speeds. Data shows mean ± SD, n = 3.  
 
Supplementary Figure 3 – Effect of aeration method on the metabolite flux of BM-hMSCs in controlled 
microcarrier culture. Showing no significant increase in (A) LDH concentration or (B) total protein with various 
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aeration methods, demonstrating low levels of cell damage during culture. Control set-points are 115rpm 
impeller speed, 25% dO2 concentration and pH 7.4. Data shows mean ± SD, n = 3.  
 
Supplementary Figure 2 - Verification of post-harvest immunophenotype and differential potential of BM-
hMSCs used during this study in accordance with the ISCT minimum criteria.   
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